Pop Biotechnologies Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Pop Biotechnologies

Access the complete profile.

Pop Biotechnologies Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	1576 Sweet Home Road, Suite 221 Buffalo, NY 14228

Note: Revenues for privately held companies are statistical evaluations.


Pop Biotechnologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Pop Biotechnologies's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Pop Biotechnologies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Pop Biotechnologies Annual Revenue and Growth Rate

Pop Biotechnologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Pop Biotechnologies's revenues are gauged from an analysis of company filings.

Pop Biotechnologies's Income Statement (based on Industry Averages)

Pop Biotechnologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Pop Biotechnologies is developing and marketing. Pop Biotechnologies doesn't have any recent trademark applications, indicating Pop Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
POP BIO Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases	12/17/2023
POP BIOTECHNOLOGIES Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases	12/17/2023
HANAFLU Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases	12/17/2023

See all trademarks and details in the Full Report.

Market Share of Pop Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Pop Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Pop Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CALSPAN	Buffalo, NY	100
AVARINT	Buffalo, NY	54
ATHENEX	Buffalo, NY	26
EMPIRICAN PRN	Buffalo, NY	15
HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE	Buffalo, NY	11
POSTPROCESS TECHNOLOGIES	Buffalo, NY	7

Future Competition: Pop Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Pop Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)